This article has been updated to include a stock quote.

NEW YORK (GenomeWeb News) – Orchid Cellmark today reported flat fourth-quarter revenues as its profit declined on higher costs for performing DNA testing services.

The Princeton, NJ-based firm brought in revenues of $15 million for the three months ended Dec. 31 compared to revenues of $14.9 million in the fourth quarter of 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.